[1]	Rudd KE, Johnson SC, Agesa KM, et al. Global,regional, and national sepsis incidence and mortality,1990-2017:analysis for the global burden of disease study[J]. Lancet, 2020, 395(10219):200-211.DOI:10.1016/s0140-6736(19)32989-7. Cited in this article [1]

[2]	Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign:international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47(11):1181-1247.DOI:10.1007/s00134-021-06506-y. Cited in this article [1]

[3]	Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign:international guidelines for management of sepsis and septic shock:2016[J]. Intensive Care Med, 2017, 43(3):304-377.DOI:10.1007/s00134-017-4683-6. Cited in this article [1]

[4]	Cecconi M, Evans L, Levy M, et al. Sepsis and septic shock[J]. Lancet, 2018, 392(10141):75-87.DOI:10.1016/s0140-6736(18)30696-2. Cited in this article [1]

[5]	Singer M, Deutschman C, Seymour C, et al. The third international consensus definitions for sepsis and septic shock(sepsis-3)[J]. JAMA, 2016, 315(8):801-810.DOI:10.1001/jama.2016.0287. Cited in this article [2]

[6]	Kane AE, Sinclair DA. Sirtuins and NAD(+)in the development and treatment of metabolic and cardiovascular diseases[J]. Circ Res, 2018, 123(7):868-885.DOI:10.1161/circresaha.118.312498. Cited in this article [1]

[7]	Tang H, Zhou Y, Ma L, et al. SIRT3 alleviates mitochondrial dysfunction and senescence in diabetes-associated periodontitis by deacetylating lrpprc[J]. Free Radic Biol Med, 2024, 227(2):407-419.DOI:10.1016/j.freeradbiomed.2024.11.033. Cited in this article [1]

[8]	Devabattula G, Bakchi B, Sharma A, et al. Mitochondria-targeting SIRT3 activator effectively controls bleomycin-induced pulmonary fibrosis[J]. Biofactors, 2025, 51(4):e70032.DOI:10.1002/biof.70032. Cited in this article [1]

[9]	Tang X, Chen XF, Chen HZ, et al. Mitochondrial sirtuins in cardiometabolic diseases[J]. Clin Sci(Lond), 2017, 131(16):2063-2078.DOI:10.1042/cs20160685. Cited in this article [1]

[10]	Bugger H, Witt CN, Bode C. Mitochondrial sirtuins in the heart[J]. Heart Fail Rev, 2016, 21(5):519-528.DOI:10.1007/s10741-016-9570-7. Cited in this article [1]

[11]

Dikalova AE, Pandey A, Xiao L, et al. Mitochondrial deacetylase SIRT3 reduces vascular dysfunction and hypertension while SIRT3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress[J]. Circ Res, 2020, 126(4):439-452.DOI:10.1161/circresaha.119.315767. Cited in this article [1]

[12]	Paulin R, Dromparis P, Sutendra G, et al. Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans[J]. Cell Metab, 2014, 20(5):827-839.DOI:10.1016/j.cmet.2014.08.011. Cited in this article [1]

[13]	Ma LL, Kong FJ, Dong Z, et al. Hypertrophic preconditioning attenuates myocardial ischaemia-reperfusion injury by modulating SIRT3-SOD2-mROS-dependent autophagy[J]. Cell Prolif, 2021, 54(7):e13051.DOI:10.1111/cpr.13051. Cited in this article [1]

[14]	Zhang M, Zhao Z, Shen M, et al. Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(8):1962-1972.DOI:10.1016/j.bbadis.2016.09.003. Cited in this article [1]

[15]	Wei Z, Yang B, Wang H, et al. Caloric restriction,sirtuins,and cardiovascular diseases[J]. Chin Med J(Engl), 2024, 137(8):921-935.DOI:10.1097/cm9.0000000000003056. Cited in this article [1]

[16]	Alqarni MH, Foudah AI, Muharram MM, et al. The pleiotropic function of human sirtuins as modulators of metabolic pathways and viral infections[J]. Cells, 2021, 10(2):460.DOI:10.3390/cells10020460. Cited in this article [1]

[17]	Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins[J]. Nature, 2009, 460(7255):587-591.DOI:10.1038/nature08197. Cited in this article [1]

[18]	Sack MN. The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging[J]. J Mol Cell Cardiol, 2012, 52(3):520-525.DOI:10.1016/j.yjmcc.2011.11.004. Cited in this article [1]

[19]	Ahn BH, Kim HS, Song S, et al. A role for the mitochondrial deacetylase SIRT3 in regulating energy homeostasis[J]. Proc Natl Acad Sci U S A, 2008, 105(38):14447-14452.DOI:10.1073/pnas.0803790105. Cited in this article [1]

[20]	Cao T, Ni R, Ding W, et al. Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis[J]. J Transl Med, 2023, 21(1):883.DOI:10.1186/s12967-023-04767-3. Cited in this article [1]

[21]	Kanwal A. Functional and therapeutic potential of mitochondrial SIRT3 deacetylase in disease conditions[J]. Expert Rev Clin Pharmacol, 2018, 11(12):1151-1155.DOI:10.1080/17512433.2018.1546119. Cited in this article [1]

[22]	Lelubre C, Vincent J. Mechanisms and treatment of organ failure in sepsis[J]. Nat Rev Nephrol, 2018, 14(7):417-427.DOI:10.1038/s41581-018-0005-7. Cited in this article [2]

[23]	Koentges C, Cimolai M, Pfeil K, et al. Impaired SIRT3 activity mediates cardiac dysfunction in endotoxemia by calpain-dependent disruption of ATP synthesis[J]. J Mol Cell Cardiol, 2019, 133(8):138-147.DOI:10.1016/j.yjmcc.2019.06.008. Cited in this article [1]

[24]	Xin T, Lu C. SIRT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury[J]. Aging(Albany NY), 2020, 12(16):16224-16237.DOI:10.18632/aging.103644. Cited in this article [2]

[25]	Xu Q, Xiong H, Zhu W, et al. Small molecule inhibition of cyclic GMP-AMP synthase ameliorates sepsis-induced cardiac dysfunction in mice[J]. Life Sci, 2020,260:118315.DOI:10.1016/j.lfs.2020.118315. Cited in this article [2]

[26]	Zhang L, Zheng YL, Hu RH, et al. Annexin A1 mimetic peptide AC2-26 inhibits sepsis-induced cardiomyocyte apoptosis through LXA4/PI3K/AKT signaling pathway[J]. Curr Med Sci, 2018, 38(6):997-1004.DOI:10.1007/s11596-018-1975-1. Cited in this article [1]

[27]	Ma W, Huang Z, Miao Y, et al. ANXA1sp modulates the protective effect of SIRT3-induced mitophagy against sepsis-induced myocardial injury in mice[J]. Acta Physiol(Oxf), 2024, 240(8):e14184.DOI:10.1111/apha.14184. Cited in this article [1]

[28]	Qin S, Ren Y, Feng B, et al. Annexin-A1 short peptide alleviates septic myocardial injury by upregulating SIRT3 and inhibiting myocardial cell apoptosis[J]. Histol Histopathol, 2024, 39(7):947-957.DOI:10.14670/hh-18-691. Cited in this article [1]

[29]	Qin S, Ren YC, Liu JY, et al. ANXA1SP attenuates sepsis-induced myocardial injury by promoting mitochondrial biosynthesis and inhibiting oxidative stress and autophagy via SIRT3 upregulation[J]. Kaohsiung J Med Sci, 2024, 40(1):35-45.DOI:10.1002/kjm2.12767. Cited in this article [1]

[30]	Liu J, Zhou G, Chen R, et al. Mitochondrial SIRT3 serves as a biomarker for sepsis diagnosis and mortality prediction[J]. Sci Rep, 2022, 12(1):10414.DOI:10.1038/s41598-022-14365-w. Cited in this article [3]

[31]	Li J, Lu K, Zhang X, et al. SIRT3-mediated mitochondrial autophagy in refeeding syndrome-related myocardial injury in sepsis rats[J]. Ann Transl Med, 2022, 10(4):211.DOI:10.21037/atm-22-222. Cited in this article [1]

[32]	Qin Y, Shi Y, Yu Q, et al. Vitamin B12 alleviates myocardial ischemia/reperfusion injury via the SIRT3/AMPK signaling pathway[J]. Biomed Pharmacother, 2023, 163(7):114761.DOI:10.1016/j.biopha.2023.114761. Cited in this article [1]

[33]	Rodrigues M, Antonucci I, Elabd S, et al. p53 is active in human amniotic fluid stem cells[J]. Stem Cells Dev, 2018, 27(21):1507-1517.DOI:10.1089/scd.2017.0254. Cited in this article [2]

[34]	Olivos DJ, Mayo LD. Emerging non-canonical functions and regulation by p53:p53 and stemness[J]. Int J Mol Sci, 2016, 17(12):1982.DOI:10.3390/ijms17121982. Cited in this article [1]

[35]	Gao N, Liu XY, Chen J, et al. Menaquinone-4 alleviates sepsis-associated acute lung injury via activating SIRT3-p53/SLC7a11 pathway[J]. J Inflamm Res, 2024, 17(1):7675-7685.DOI:10.2147/jir.S486984. Cited in this article [1]

[36]	Jing X, Chen Z, Zhang M, et al. Melatonin mitigates the lipopolysaccharide-induced myocardial injury in rats by blocking the p53/xCT pathway-mediated ferroptosis[J]. Naunyn Schmiedebergs Arch Pharmacol, 2025, 398(2):1653-1663.DOI:10.1007/s00210-024-03367-2. Cited in this article [1]

[37]

Ning L, Rui X, Guorui L, et al. A novel mechanism for the protection against acute lung injury by melatonin:mitochondrial quality control of lung epithelial cells is preserved through SIRT3-dependent deacetylation of SOD2[J]Cell Mol Life Sci, 2022, 79(12):610.DOI:10.1007/s00018-022-04628-0. Cited in this article [1]

[38]	Sun M, Li Y, Xu G, et al. Sirt3-mediated OPA1 deacetylation protects against sepsis-induced acute lung injury by inhibiting alveolar macrophage pro-inflammatory polarization[J]. Antioxid Redox Signal, 2024, 41(16-18):1014-1030.DOI:10.1089/ars.2023.0322. Cited in this article [1]

[39]	Shen W, Zhao X, Li S. Exosomes derived from ADSCs attenuate sepsis-induced lung injury by delivery of Circ-Fryl and regulation of the miR-490-3p/SIRT3 pathway[J]. Inflammation, 2022, 45(1):331-342.DOI:10.1007/s10753-021-01548-2. Cited in this article [1]

[40]	Xia W, Pan Z, Zhang H, et al. ERRα protects against sepsis-induced acute lung injury in rats[J]. Mol Med, 2023, 29(1):76.DOI:10.1186/s10020-023-00670-1. Cited in this article [1]

[41]	Wang J, Li W, Zhao F, et al. Sirt3 regulates NLRP3 and participates in the effects of plantainoside d on acute lung injury sepsis[J]. Aging(Albany NY), 2023, 15(14):6710-6720.DOI:10.18632/aging.204628. Cited in this article [1]

[42]

Li X, Wang S, Luo M, et al. Carnosol alleviates sepsis-induced pulmonary endothelial barrier dysfunction by targeting nuclear factor erythroid2-related factor 2/sirtuin-3 signaling pathway to attenuate oxidative damage[J]. Phytother Res, 2024, 38(5):2182-2197.DOI:10.1002/ptr.8138. Cited in this article [1]

[43]	Xin W, Zhou J, Peng Y, et al. SREBP1c-mediated transcriptional repression of YME1L1 contributes to acute kidney injury by inducing mitochondrial dysfunction in tubular epithelial cells[J]. Adv Sci(Weinh), 2025, 12(6):e2412233.DOI:10.1002/advs.202412233. Cited in this article [1]

[44]	Morevati M, Fang EF, Mace ML, et al. Roles of NAD(+) in acute and chronic kidney diseases[J]. Int J Mol Sci, 2022, 24(1):137.DOI:10.3390/ijms24010137. Cited in this article [1]

[45]	Jian Y, Yang Y, Cheng L, et al. SIRT3 mitigates LPS-induced mitochondrial damage in renal tubular epithelial cells by deacetylating YME1L1[J]. Cell Prolif, 2023, 56(2):e13362.DOI:10.1111/cpr.13362. Cited in this article [1]

[46]	Sun C, Xiong H, Guo T. β-Nicotinamide mononucleotide alleviates sepsis-associated acute kidney injury by activating NAD+/Sirt3 signaling[J]. Cell Biochem Biophys, 2025, 83(2):2089-2099.DOI:10.1007/s12013-024-01619-9. Cited in this article [1]

[47]	Morigi M, Perico L, Rota C, et al. Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury[J]. J Clin Invest, 2015, 125(2):715-726.DOI:10.1172/jci77632. Cited in this article [1]

[48]	Fan H, Le J, Sun M, et al. Sirtuin 3 deficiency promotes acute kidney injury induced by sepsis via mitochondrial dysfunction and apoptosis[J]. Iran J Basic Med Sci, 2021, 24(5):675-681.DOI:10.22038/ijbms.2021.54905.12312. Cited in this article [1]

[49]	Jin K, Ma Y, Manrique-Caballero C, et al. Activation of AMP-activated protein kinase during sepsis/inflammation improves survival by preserving cellular metabolic fitness[J]. FASEB J, 2020, 34(5):7036-7057.DOI:10.1096/fj.201901900R. Cited in this article [1]

[50]	Sun M, Wang F, Li H, et al. Maresin-1 attenuates sepsis-associated acute kidney injury via suppressing inflammation,endoplasmic reticulum stress and pyroptosis by activating the AMPK/Sirt3 pathway[J]. J Inflamm Res, 2024, 17(1):1349-1364.DOI:10.2147/jir.S442729. Cited in this article [1]

[51]	Gan Y, Tao S, Cao D, et al. Protection of resveratrol on acute kidney injury in septic rats[J]. Hum Exp Toxicol, 2017, 36(10):1015-1022.DOI:10.1177/0960327116678298. Cited in this article [1]

[52]	Fan H, Le JW, Sun M, et al. N-acetylcysteine protects septic acute kidney injury by inhibiting Sirt3-mediated mitochondrial dysfunction and apoptosis[J]. Iran J Basic Med Sci, 2024, 27(7):850-856.DOI:10.22038/ijbms.2024.72882.15853. Cited in this article [1]

[53]	Deng Z, He M, Hu H, et al. Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy through Sirt3-mediated TFAM deacetylation[J]. Autophagy, 2024, 20(1):151-165.DOI:10.1080/15548627.2023.2252265. Cited in this article [1]

[54]	Tan C, Gu J, Li T, et al. Inhibition of aerobic glycolysis alleviates sepsis-induced acute kidney injury by promoting lactate/sirtuin 3/AMPK-regulated autophagy[J]. Int J Mol Med, 2021, 47(3):19.DOI:10.3892/ijmm.2021.4852. Cited in this article [1]

[55]	Yuan Y, Yuan L, Yang J, et al. Autophagy-deficient macrophages exacerbate cisplatin-induced mitochondrial dysfunction and kidney injury via miR-195a-5p-Sirt3 axis[J]. Nat Commun, 2024, 15(1):4383.DOI:10.1038/s41467-024-47842-z. Cited in this article [1]

[56]	Strnad P, Tacke F, Koch A, et al. Liver-guardian,modifier and target of sepsis[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(1):55-66.DOI:10.1038/nrgastro.2016.168. Cited in this article [1]

[57]	Van den Broecke A, Van Coile L, Decruyenaere A, et al. Epidemiology,causes, evolution and outcome in a single-center cohort of 1 116 critically ill patients with hypoxic hepatitis[J]. Ann Intensive Care, 2018, 8(1):15.DOI:10.1186/s13613-018-0356-z.

[58]	Spirlì C, Fabris L, Duner E, et al. Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes[J]. Gastroenterology, 2003, 124(3):737-753.DOI:10.1053/gast.2003.50100.

[59]	Spirlì C, Nathanson MH, Fiorotto R, et al. Proinflammatory cytokines inhibit secretion in rat bile duct epithelium[J]. Gastroenterology, 2001, 121(1):156-169.DOI:10.1053/gast.2001.25516.

[60]	Zheng Z, Ma H, Zhang X, et al. Enhanced glycolytic metabolism contributes to cardiac dysfunction in polymicrobial sepsis[J]. J Infect Dis, 2017, 215(9):1396-1406.DOI:10.1093/infdis/jix138. Cited in this article [1]

[61]	Liu Z, Guo J, Sun H, et al. α-Lipoic acid attenuates LPS-induced liver injury by improving mitochondrial function in association with GR mitochondrial DNA occupancy[J]. Biochimie, 2015, 116(9):52-60.DOI:10.1016/j.biochi.2015.06.023. Cited in this article [2]

[62]	Shulga N, Pastorino J. Hexokinase Ⅱ binding to mitochondria is necessary for Kupffer cell activation and is potentiated by ethanol exposure[J]. J Biol Chem, 2016, 291(24):12574.DOI:10.1074/jbc.A114.580175. Cited in this article [1]

[63]	Kim A, Koo JH, Lee JM, et al. NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced liver injury[J]. FASEB J, 2022, 36(3):e22170.DOI:10.1096/fj.202101470R. Cited in this article [1]

[64]	Li R, Xin T, Li D, et al. Therapeutic effect of sirtuin 3 on ameliorating nonalcoholic fatty liver disease:the role of the ERK-CREB pathway and Bnip3-mediated mitophagy[J]. Redox Biol, 2018, 18(5):229-243.DOI:10.1016/j.redox.2018.07.011. Cited in this article [1]

[65]	Ning Y, Dou X, Wang Z, et al. SIRT3:a potential therapeutic target for liver fibrosis[J]. Pharmacol Ther, 2024, 257(5):108639.DOI:10.1016/j.pharmthera.2024.108639. Cited in this article [1]

[66]	Han X, Ning Y, Dou X, et al. Cornus officinalis with high pressure wine steaming enhanced anti-hepatic fibrosis:possible through SIRT3-AMPK axis[J]. J Pharm Anal, 2024, 14(5):100927.DOI:10.1016/j.jpha.2023.12.017. Cited in this article [1]

[67]	Li M, Li C, Ye Z, et al. SIRT3 modulates fatty acid oxidation and attenuates cisplatin-induced AKI in mice[J]. J Cell Mol Med, 2020, 24(9):5109-5121.DOI:10.1111/jcmm.15148. Cited in this article [1]

[68]	Su G. Lipopolysaccharides in liver injury:molecular mechanisms of Kupffer cell activation[J]. Am J Physiol Gastrointest Liver Physiol, 2002, 283(2):G256-G265.DOI:10.1152/ajpgi.00550.2001. Cited in this article [1]

[69]	Yan J, Li S, Li S. The role of the liver in sepsis[J]. Int Rev Immunol, 2014, 33(6):498-510.DOI:10.3109/08830185.2014.889129. Cited in this article [1]

[70]	Brun-Buisson C, Meshaka P, Pinton P, et al. EPISEPSIS:a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units[J]. Intensive Care Medicine, 2004, 30(4):580-588.DOI:10.1007/s00134-003-2121-4. Cited in this article [1]

[71]	Vincent J, Angus D, Artigas A, et al. Effects of drotrecogin alfa(activated)on organ dysfunction in the PROWESS trial[J]. Crit Care Med, 2003, 31(3):834-840.DOI:10.1097/01.Ccm.0000051515.56179.E1. Cited in this article [1]

[72]	Sun J, Zhang J, Wang X, et al. Gut-liver crosstalk in sepsis-induced liver injury[J]. Crit Care, 2020, 24(1):614.DOI:10.1186/s13054-020-03327-1. Cited in this article [1]

[73]	Pei L, Li R, Wang X, et al. MSCs-derived extracellular vesicles alleviate sepsis-associated liver dysfunction by inhibiting macrophage glycolysis-mediated inflammatory response[J]. Int Immunopharmacol, 2024, 128(3):111575.DOI:10.1016/j.intimp.2024.111575. Cited in this article [1]

[74]	Xiao D, Wang X, Liang W, et al. Convergence of sepsis-associated encephalopathy pathogenesis onto microglia[J]. J Transl Med, 2025, 23(1):622.DOI:10.1186/s12967-025-06635-8. Cited in this article [1]

[75]	Hosokawa K, Gaspard N, Su F, et al. Clinical neurophysiological assessment of sepsis-associated brain dysfunction:a systematic review[J]. Crit Care(Lond), 2014, 18(6):674.DOI:10.1186/s13054-014-0674-y. Cited in this article [1]

[76]	Gofton T, Young G. Sepsis-associated encephalopathy[J]. Nat Rev Neurol, 2012, 8(10):557-566.DOI:10.1038/nrneurol.2012.183. Cited in this article [1]

[77]	He C, Aziguli A, Zhen J, et al. MiRNA-494 specifically inhibits SIRT3-mediated microglia activation in sepsis-associated encephalopathy[J]. Transl Cancer Res, 2022, 11(7):2299-2309.DOI:10.21037/tcr-22-1732. Cited in this article [1]

[78]	Gareau MG. The microbiota-gut-brain axis in sepsis-associated encephalopathy[J]. mSystems, 2022, 7(4):e0053322.DOI:10.1128/msystems.00533-22. Cited in this article [1]

[79]	Wang X, Wen X, Yuan S, et al. Gut-brain axis in the pathogenesis of sepsis-associated encephalopathy[J]. Neurobiol Dis, 2024, 195(6):106499.DOI:10.1016/j.nbd.2024.106499. Cited in this article [1]

[80]	Sun F, Si Y, Bao H, et al. Regulation of sirtuin 3-mediated deacetylation of cyclophilin d attenuated cognitive dysfunction induced by sepsis-associated encephalopathy in mice[J]. Cell Mol Neurobiol, 2017, 37(8):1457-1464.DOI:10.1007/s10571-017-0476-2. Cited in this article [1]

[81]	Iba T, Levy J, Warkentin T, et al. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation[J]. J Thromb Haemost, 2019, 17(11):1989-1994.DOI:10.1111/jth.14578. Cited in this article [1]

[82]	Hunt B. Bleeding and coagulopathies in critical care[J]. N Engl J Med, 2014, 370(9):847-859.DOI:10.1056/NEJMra1208626. Cited in this article [1]

[83]	Gando S, Fujishima S, Saitoh D, et al. The significance of disseminated intravascular coagulation on multiple organ dysfunction during the early stage of acute respiratory distress syndrome[J]. Thromb Res, 2020, 191(7):15-21.DOI:10.1016/j.thromres.2020.03.023. Cited in this article [1]

[84]	Iba T, Levy J. Inflammation and thrombosis:roles of neutrophils,platelets and endothelial cells and their interactions in thrombus formation during sepsis[J]. J Thromb Haemost, 2018, 16(2):231-241.DOI:10.1111/jth.13911. Cited in this article [1]

[85]	Ahamed J, Niessen F, Kurokawa T, et al. Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia[J]. Blood, 2007, 109(12):5251-5259.DOI:10.1182/blood-2006-10-051334. Cited in this article [1]

[86]	Iba T, Miki T, Hashiguchi N, et al. Is the neutrophil a ‘prima donna’ in the procoagulant process during sepsis[J]. Crit Care(Lond), 2014, 18(4):230.DOI:10.1186/cc13983. Cited in this article [1]

[87]	Matsumoto H, Yamakawa K, Ogura H, et al. Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation[J]. Shock, 2015, 43(5):443-449.DOI:10.1097/shk.0000000000000331. Cited in this article [1]

[88]	Kudo D, Goto T, Uchimido R, et al. Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin:an analysis of three multicentre observational studies[J]. Crit Care(Lond), 2021, 25(1):114.DOI:10.1186/s13054-021-03541-5. Cited in this article [1]

[89]	Zhang P, Zhao T, Zhou W. The clinical significance of SIRT3 in COVID-19 patients:a single center retrospective analysis[J]. Ann Clin Lab Sci, 2021, 51(5):686-693. Cited in this article [1]

[90]	Gaul D, Weber J, van Tits L, et al. Loss of SIRT3 accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity[J]. Cardiovasc Res, 2018, 114(8):1178-1188.DOI:10.1093/cvr/cvy036. Cited in this article [1]

[91]	Greco E, Lupia E, Bosco O, et al. Platelets and multi-organ failure in sepsis[J]. Int J Mol Sci, 2017, 18(10):2200.DOI:10.3390/ijms18102200. Cited in this article [1]

[92]	Fuchs T, Bhandari A, Wagner D. Histones induce rapid and profound thrombocytopenia in mice[J]. Blood, 2011, 118(13):3708-3714.DOI:10.1182/blood-2011-01-332676. Cited in this article [1]

[93]	Lv D, Luo M, Yan J, et al. Protective effect of sirtuin 3 on CLP-induced endothelial dysfunction of early sepsis by inhibiting NF-κB and NLRP3 signaling pathways[J]. Inflammation, 2021, 44(5):1782-1792.DOI:10.1007/s10753-021-01454-7. Cited in this article [1]

[94]	van der Poll T, Shankar-Hari M, Wiersinga W. The immunology of sepsis[J]. Immunity, 2021, 54(11):2450-2464.DOI:10.1016/j.immuni.2021.10.012. Cited in this article [1]

[95]	Zhang C, Zhang C, Wang H. Immune-checkpoint inhibitor resistance in cancer treatment:current progress and future directions[J]. Cancer Lett, 2023, 562(11):216182.DOI:10.1016/j.canlet.2023.216182. Cited in this article [1]

[96]	Liu T, Vachharajani V, Millet P, et al. Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis[J]. J Biol Chem, 2015, 290(1):396-408.DOI:10.1074/jbc.M114.566349. Cited in this article [1]

[97]	Cajander S, Kox M, Scicluna BP, et al. Profiling the dysregulated immune response in sepsis:overcoming challenges to achieve the goal of precision medicine[J]. Lancet Respir Med, 2024, 12(4):305-322.DOI:10.1016/s2213-2600(23)00330-2. Cited in this article [1]

[98]	He Y, Huang B, Yang Y, et al. MicroRNA-16-5p exacerbates sepsis by upregulating aerobic glycolysis via SIRT3-SDHA axis[J]. Cell Biol Int, 2022, 46(12):2207-2219.DOI:10.1002/cbin.11908. Cited in this article [1]